Since COVID, the balance of power in hiring biotechnology has shifted towards employees. What do companies now need to know about candidate motivation and how can they adjust their offerings to gain more talent? It’s psychological, says Tom Froggatt, MD for Singular Talent, a biotech recruiter.
It has become more difficult for biotech companies – especially those at an early stage where the risk is higher – to access the talents they need…
This article is available to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, reviews and comments of the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user, log in. If your rehearsal has come to an end, you can subscribe here.
Try before you buy
• All the news that drives the needle in pharmacy and biotechnology.
• Exclusive features, podcasts, interviews, data analysis and comments from our global network of life science journalists.
• Receive The Pharma Letter newsletter, free forever.
Become a subscriber
• Unhindered access to leading news, commentary and analysis in pharmacy and biotechnology.
• Updates from clinical trials, conferences, M&A, licensing, funding, regulation, patents and legal, CEO appointments, commercial strategy and financial results.
• Daily overview of key events in pharmacy and biotechnology.
• Monthly detailed briefings on appointments in boardrooms and news on mergers and acquisitions.
• Choose between a cost-effective annual package or a flexible monthly subscription.